DBV Technologies S.A. (DBVT)
NASDAQ: DBVT · Real-Time Price · USD
14.14
-0.41 (-2.82%)
At close: Aug 24, 2026, 4:00 PM EDT
14.74
+0.60 (4.24%)
Pre-market: Aug 25, 2026, 5:06 AM EDT
DBV Technologies Market Cap
DBV Technologies has a market cap or net worth of $841.82 million as of August 25, 2026. Its market cap has increased by 207.35% in one year.
Market Cap
841.82M
Enterprise Value
671.05M
1-Year Change
207.35%
Ranking
Category
Stock Price
$14.14
ChartMarket Cap Chart
Since October 22, 2014, DBV Technologies's market cap has decreased from $844.80M to $841.82M, a decrease of -0.35%. That is a compound annual growth rate of -0.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 841.82M | 29.83% |
| Dec 31, 2025 | 648.40M | 987.92% |
| Dec 31, 2024 | 59.60M | -67.52% |
| Dec 29, 2023 | 183.50M | -36.22% |
| Dec 30, 2022 | 287.70M | 63.47% |
| Dec 31, 2021 | 176.00M | -28.57% |
| Dec 31, 2020 | 246.40M | -68.16% |
| Dec 31, 2019 | 773.80M | 141.13% |
| Dec 31, 2018 | 320.90M | -73.54% |
| Dec 29, 2017 | 1.21B | -28.69% |
| Dec 30, 2016 | 1.70B | 22.23% |
| Dec 31, 2015 | 1.39B | 39.07% |
| Dec 31, 2014 | 1.00B | 18.43% |
| Oct 22, 2014 | 844.80M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Attovia Therapeutics | 887.26M |
| Theravance Biopharma | 883.14M |
| SpyGlass Pharma | 878.34M |
| 4D Molecular Therapeutics | 850.21M |
| Rigel Pharmaceuticals | 842.65M |
| Aura Biosciences | 819.27M |
| Achieve Life Sciences | 817.05M |
| Pharming Group | 814.98M |